Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/26/24 18:15 | 9/26/24 | TECX | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT | P | 1,441 | 28.82 | 0 | 50 | 1 | 4,293 | M | |||||||||||||||
5/15/24 11:21 | 5/13/24 | AVRO | Health | BioPrd | Biological Products, (No Diag | Leonard Braden Michael | IN | T | P.m | 971 | 1.27 | 0 | 767 | 17 | 5,168 | I | |||||||||||||||
2/5/24 20:01 | 2/1/24 | AVRO | Health | BioPrd | Biological Products, (No Diag | Golipour Azadeh | MA | O | CTO | M.d | 0 | 0.00 | 0 | 37 | 201 | 56 | D | ||||||||||||||
2/5/24 19:59 | 2/1/24 | AVRO | Health | BioPrd | Biological Products, (No Diag | Ridha Essra | MA | O | Chief Me | M.d | 0 | 0.00 | 0 | 33 | 16 | D | |||||||||||||||
2/5/24 19:57 | 2/1/24 | AVRO | Health | BioPrd | Biological Products, (No Diag | Ostrowski Erik | MA | O | Interim | M.d | 0 | 0.00 | 0 | 40 | 29 | D | |||||||||||||||
2/5/24 19:56 | 2/1/24 | AVRO | Health | BioPrd | Biological Products, (No Diag | Avruch Steven | MA | O | GC | M.d | 0 | 0.00 | 0 | 33 | 22 | D | |||||||||||||||
1/26/23 17:30 | 1/24/23 | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | P,CEO | M.d | 42 | 0.9100 | 0 | 46 | 6 | 778 | M | ||||||||||||||
12/28/22 19:18 | 12/23/22 | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | P,CEO | M.d | 59 | 0.4132 | 0 | 142 | 24 | 732 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |